February 18, 2013
The Ministry of Health, Labor and Welfare (MHLW) on February 15 granted marketing approval for a generic version of Kowa Company’s hyperlipidemia treatment Livalo (pitavastatin calcium), but the original maker says that what would have been the first authorized generic...read more